InvestSMART

AVITA Medical, Inc. (ASX:AVH)

ALERT: Price-sensitive ASX Announcement for AVH
Current share price for AVH : $1.270 0.18 (16.51%)+
Announcement
Release
13 Feb 2026 9:40AM
Price at Release
$1.090
Full Release
download
Summary
AVITA Medical, Inc. reported its financial performance and operational highlights for the year ended December 31, 2025. The company experienced a net loss of $48.6 million, an improvement from the previous year's loss of $61.8 million. Total revenues increased to $71.6 million, driven by sales and lease revenue, despite a rise in operating expenses. AVITA's balance sheet showed total assets of $56.4 million, with cash and equivalents at $10.2 million. The company continued to focus on its strategic initiatives, including expanding market presence and product development, while managing its liabilities and equity deficit effectively. Additionally, AVITA executed agreements and amendments to enhance its operational capabilities and investor relations.
Key Points
  • Net loss decreased to $48.6 million from $61.8 million.
  • Total revenues grew to $71.6 million.
  • Cash and cash equivalents amounted to $10.2 million.
  • Operating expenses increased, affecting profitability.
  • Strategic initiatives focused on market expansion and product development.
  • Executed agreements and amendments to bolster operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.